Summary: Before the Diagnosis
When You Notice Your Own Mind Changing
She is sixty-eight, a retired teacher, and she has started closing browser tabs before the search results load. She types “early signs of Alzheimer’s” into Google at 2 AM, then stops. Goes back to bed. She knows something is different. She cannot name it, cannot prove it, but the quality of this forgetting is not the same as misplacing keys. She has not told anyone. This is the space before diagnosis. It can last months or years. It is one of the loneliest places a person can be.
Researchers call this middle ground subjective cognitive decline: people who notice changes in their own thinking but perform normally on standard tests. Approximately one in four adults over sixty report cognitive concerns. Most will never develop dementia. Some will. The terror of the question keeps many people silent for years.
Science can now see more than it could. In May 2025, the FDA cleared the first blood test for Alzheimer’s pathology, measuring two proteins with roughly 92% accuracy compared to PET imaging. For the first time, a primary care physician can order a blood test that provides meaningful information about Alzheimer’s risk. Beyond blood tests, AI-powered tools analyzing speech patterns, gait changes, and retinal images are in development, some close to clinical use, others years away. None replaces a thorough professional evaluation.
The paradox of knowing early is real. For someone with symptoms, early detection now has clinical meaning: the FDA-approved treatments lecanemab and donanemab work only in early-stage disease. Detecting pathology early opens a treatment window. For someone without symptoms, the calculus is more complicated. Two large trials are testing whether treatment before symptoms can delay decline. Results are years away.
Access matters. Blood tests require laboratory infrastructure and clinician education that are unevenly distributed. The communities at highest risk, including Black and Hispanic Americans, are often the least likely to have access.
If you are noticing changes, the first step is the hardest: say it out loud. Talk to your doctor with specifics. Ask for a MoCA screening. Ask about blood biomarker testing and understand what a result would mean for you. The people who love you will likely be less surprised than you expect. Many of them have noticed. They have been waiting for you to be ready to talk.